Results 191 to 200 of about 1,107,201 (376)
FDA Manufacturer Evaluation Result Code Hierarchy [PDF]
National Cancer Institute
openalex +1 more source
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma [PDF]
Elaine Chang +18 more
openalex +1 more source
This work presents a novel, dynamically perfused, configurable microfluidic system for epidermis‐only (E and full‐thickness skin (FT SoC) growth, emulating human skin structure and barrier function. Upon TiO2 nanoparticle exposure, the system reveals compromised barrier integrity, reduced metabolic activity, increased permeability, and chemokine‐driven
Samantha Costa +7 more
wiley +1 more source
Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship [PDF]
Timil H. Patel +11 more
openalex +1 more source
Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update.
R. Roskoski
semanticscholar +1 more source
A methacrylamide β‐cyclodextrin‐based nanogel (MACD nGel) is developed to load the antimicrobial drug Metronidazole (MNZ) for topical delivery for the treatment of periodontitis. It is demonstrated that cyclodextrin nanogel (nGel) loaded with metronidazole provides an efficient drug delivery route but also has potential clinical applications and offers
Yanjing Ji +8 more
wiley +1 more source
A vapor‐based porous coating applied within nitinol tubes demonstrated complete suppression of cellular and tissue ingrowth, overcoming a major limitation of implantable interstitial fluid collection devices. Molecular channeling and diffusion are analyzed with probe molecules, showing reliable transport in vitro and in vivo. The coating also achieved >
Yu‐Ming Chang +8 more
wiley +1 more source
The FDA's plan to phase out animal testing. [PDF]
Gerke S, Balamut J, Wagner JK.
europepmc +1 more source

